Comparison of the effects of antipsychotics on a delayed radial maze task in the rat

Psychopharmacology

Volumn 168, Issue 4, 2003, Pages 410-416

  Wolff, Mary C ^a   Leander, J David ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Atypical antipsychotics; Cognition; Olanzapine; Radial arm maze

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; ZIPRASIDONE;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; MALE; MAZE TEST; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECALL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD DEPRIVATION; HALOPERIDOL; MALE; MAZE LEARNING; MEMORY; PIPERAZINES; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; THIAZOLES;

EID: 0041737724     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1449-3     Document Type: Article

References (37)

1. Aravagiri M, Marder SR (2002) Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats. Psychopharmacology 159:424-431
2. Aravagiri M, Teper Y, Marder SR (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 20:369-377
3. Arnt J, Skarsfeldt T (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18:63-101
4. Bakshi VP, Geyer MA (1995) Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology 122:198-201
5. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9:117-124
6. Bartus RT (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 163:495-529
7. Beatty WW, Rush JR (1983) Spatial working memory in rats: effects of monoaminergic antagonists. Pharmacol Biochem Behav 18:7-12
8. Breier A, Schreiber JL, Dyer J, Pickar D (1991) National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 48:239-246
9. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96
10. 6 receptors by olanzapine. Eur J Pharmacol 430:341-349
11. Chengappa KN, Pollock H, Levine J, Kirshner MA, Brar JS, Zoretich RA (2000) Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J Clin Psychopharmacol 20:311-316
12. Dawson LA, Huy Q, Nguyen BS, Li P (2001) The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25:662-668
13. Grant S, Fitton A (1994) Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs 48:253-273
14. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330
15. Green MF, Marshall BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS, Mintz J (1997) Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry 154:799-804
16. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002) Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26:325-339
17. Levin ED, Johansson PE (1988) Cognitive effects of long-term chronic neuroleptic drug administration. Toxicologist 8:77
18. Markowska A, Buresova O, Bures J (1983) An attempt to account for controversial estimates of working memory persistence in the radial maze. Behav Neural Biol 38:97-112
19. Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255
20. Moore NA (1999) Behavioral pharmacology of the new generation of antipsychotic agents. Br J Psychiatry 174:5-11
21. Moore NA, Leander JD, Benvenga MJ, Gleason SD, Shannon H (1997) Behavioral pharmacology of olanzapine: a novel antipsychotic drug. J Clin Psychiatry 58:37-44
22. Nowakowska E, Chodera A, Kus K, Rybakowski J (1999) Some behavioural effects of risperidone in rats: comparison with haloperidol. Eur Neuropsychopharmacol 9:421-426
23. Pilcher JJ, Sessions GR, McBride SA (1997) Scopolamine impairs spatial working memory in the radial maze: an analysis by error type and arm choice. Pharmacol Biochem Behav 58:449-459
24. Ploeger GE, Spruijt BM, Cools AR (1992) Effects of haloperidol on the acquisition of a spatial learning task. Pharmacol Behav 52:979-983
25. 3H-labeled ziprasidone. Drug Metab Dispos 25:206-218
26. Purdon SE (1999) Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophr Res 35 S51-60
27. Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD (2000) Neuropsychological change in early schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 57:249-258
28. Pussinen R, Sirvio J (1999) Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial arm maze. J Psychopharmacol 13:171-179
29. 6 antagonist SB-271046. Br J Pharmacol 127:22P
30. Schmidt AW, Lebel LA, Howard HR, Zorn SH (2001) Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425:197-201
31. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583-594
32. Skarsfeldt T (1996) Differential effect of antipsychotics on place navigation of rats in the Morris water maze. A comparative study between novel and reference antipsychotics. Psychopharmacology 124:126-133
33. Spohn HE, Strauss ME (1989) Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 98:367-380
34. Staubli U, Rogers G, Lynch G (1994) Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci USA 91:777-781
35. Strijkstra AM, Bolhuis JJ (1987) Memory persistence of rats in a radial maze varies with training procedure. Behav Neural Biol 47:158-66
36. Tollefson GD (1996) Cognitive function in schizophrenic patients. J Clin Psychiatry 57:31-39
37. Xi-Ming L, Perry KW, Wong DT, Bymaster FP (1998) Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153-161